Clinical trials
Phase 3 trials in Czechia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
3,104 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 11 |
| 2001 | 17 |
| 2002 | 30 |
| 2003 | 51 |
| 2004 | 62 |
| 2005 | 76 |
| 2006 | 114 |
| 2007 | 111 |
| 2008 | 123 |
| 2009 | 115 |
| 2010 | 121 |
| 2011 | 148 |
| 2012 | 133 |
| 2013 | 145 |
| 2014 | 149 |
| 2015 | 156 |
| 2016 | 133 |
| 2017 | 156 |
| 2018 | 150 |
| 2019 | 145 |
| 2020 | 133 |
| 2021 | 155 |
| 2022 | 137 |
| 2023 | 140 |
| 2024 | 138 |
| 2025 | 152 |
| 2026 | 73 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,996 |
| Active, not recruiting | 383 |
| Terminated | 354 |
| Recruiting | 298 |
| Unknown status | 32 |
| Enrolling by invitation | 20 |
| Withdrawn | 13 |
| Not yet recruiting | 5 |
| Suspended | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 191 |
| AstraZeneca | 139 |
| Sanofi | 136 |
| Hoffmann-La Roche | 134 |
| Pfizer | 130 |
| Eli Lilly and Company | 113 |
| GlaxoSmithKline | 112 |
| Amgen | 92 |
| Bristol-Myers Squibb | 90 |
| Janssen Research & Development, LLC | 85 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 148 |
| Breast Neoplasms | 95 |
| Carcinoma, Non-Small-Cell Lung | 79 |
| Neoplasms | 72 |
| Arthritis, Rheumatoid | 69 |
| Multiple Myeloma | 68 |
| Crohn Disease | 64 |
| Pulmonary Disease, Chronic Obstructive | 62 |
| Diabetes Mellitus | 60 |
| Prostatic Neoplasms | 60 |
Trials
Showing 1 to 25 of 3,104. Each trial links to its page on Pharma Observatory.
3,004 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.